Science & Enterprise subscription

Follow us on Twitter

  • Exclusive to Science & Enterprise ... An organization for redressing health disparities faced by women awarded a ne… https://t.co/nzlQAjGIZf
    about 6 hours ago
  • Exclusive to Science and Enterprise: Women’s Heart Health Diagnostics in the Works https://t.co/0rrQ5NLaDH #Science… https://t.co/fYwYiGHJhf
    about 6 hours ago
  • A new company, spun off from university biomedical engineering labs, is creating cancer diagnostics by analyzing mi… https://t.co/XvwdRSaAqJ
    about 23 hours ago
  • New post on Science and Enterprise: Start-Up Developing Microbial Cancer Detection Tests https://t.co/jJyKDfFQPz #Science #Business
    about 23 hours ago
  • An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorde… https://t.co/kw5ISn5tuD
    about 1 day ago

Please share Science & Enterprise

Glove-App System Translates Sign Language to Speech

Sign language translation glove

University engineers designed a glove with electronic sensors that sends signals to a smartphone app to translate American Sign Language into audible speech. . . . → Read More: Glove-App System Translates Sign Language to Speech

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 illustration

Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine. . . . → Read More: Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 Therapies Designed with Virtual Reality, A.I.

SARS-CoV-2 protease

Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed. . . . → Read More: Covid-19 Therapies Designed with Virtual Reality, A.I.

Stem Cell Therapy Licensed for Genetic Eye Disease

Red-blue-green eye

A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease

Venture Deals Decline in Q1, Biotech Sizzles Again

The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors. . . . → Read More: Venture Deals Decline in Q1, Biotech Sizzles Again

Five Covid-19 Vaccines in Clinical Trials

Coronavirus face mask

A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage. . . . → Read More: Five Covid-19 Vaccines in Clinical Trials

Infographic – Covid-19 Global Spread Near Complete

Covid-19 map

Covid-19 is truly a global pandemic, and today we offer a new map showing where the disease has spread. . . . → Read More: Infographic – Covid-19 Global Spread Near Complete

Biotech Partners for A.I. Drug Discovery in $1B Deal

Artificial intelligence graphic

Two companies are collaborating on the use of artificial intelligence to find new drugs addressing a set of proteins that regulate immune-related functions, including inflammation. . . . → Read More: Biotech Partners for A.I. Drug Discovery in $1B Deal

Intl Group Calls for More Coronavirus Vaccines

Hong Kong residents in masks

An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines